MEA Interventional Neurology Market

MEA Interventional Neurology Market Size (2023 to 2028)

The Middle East and Africa Interventional Neurology Market size was worth USD 183.26 million in 2023 and estimated to reach USD 276.32 million by the end of 2028, with a growing potential of 8.56%.

The occurrence rate of stroke has been estimated to be 316 per 100,000 every year in Africa. In turn, it will lead to growing occurrences of neurological disorders, which are set to bolster the market demand. The existence of a vast patient population and rising senior population are leveraging the market growth. The growing number of healthcare problems and increasing huge cases pertaining to diseases are likely to increase the demand for interventional neurology. Adoption of unhealthy dietary habits and lifestyle changes are surging the market growth. The high, increasing occurrence of brain stroke and aneurysm are majorly responsible for the growing demand for the neurology devices market. With rising cases of obesity in people, expansion in per capita income is mounting the market growth.

However, strict administrative policies by the U.S FDA for approving the neurology devices are likely to restrain the market growth. The scarcity of experienced professionals in neurology is curbing the growing demand for the interventional neurology market.

This market research report on the Middle East and Africa Neurovascular Devices/Interventional Neurology Market has been segmented and sub-segmented into the following categories.

By Technology: 

• Embolization and Coiling
• Balloon Angioplasty
• Carotid Stenting
• Neurothrombectomy
• Micro Support Devices

By Product: 

• Carotid Stent
• Microcatheter
• Flow Diversion
• Microguidewires
• Suction Device
• Stenting Systems
• Clot Retrieval

By End User: 

• Hospitals
• Ambulatory Centers
• Neurology Clinics

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Regional Analysis:

Geographically, South Africa is leading the market with the majority of the share. Intensifying difficulties in treating patients suffering from stroke are leveraging the growth of the market. Accessibility of favorable reimbursement policies in the healthcare sector and identifying the advantages of the interventional neurology market intensifies the growth. The introduction of new technology advancements, a huge patient population, and an increase in efficient neurovascular are escalating the market demand. UAE is next to South Africa and is leading the market. The aging population in UAE, aged 65years and above, was 1,13,000, and the count is predicted to reach 5,48,000 by the end of 2030. UAE is having a vast older population leading to a growing requirement for neurological diseases associated treatment impelling the market. The rest of the MEA is expected to have notable growth in the market.

Key players in the Middle East and Africa Interventional Neurology Market are Stryker Corporation, Merit Medical Systems Inc., Medtronic plc, Terumo Corporation, Johnson & Johnson, Microport Scientific Corporation, Penumbra Inc., Abbott Laboratories, W. L. Gore & Associates Inc., and Medikit Co., Ltd.